Table 3. Associations with abnormal contractile response.
The strength of association among each individual parameter with an abnormal contractile response (CR) was evaluated using univariable binary logistic regression; i.e. abnormal CR (impaired/disordered, absent, or spastic-reactive) was utilized as the dependent variable. hpf – high-powered field. Ref = reference category.
| Univariable | B (SE) | OR (95% CI) | P |
|---|---|---|---|
| Age | 0.03 (0.01) | 1.0 (1.0–1.1) | 0.015 |
| Sex (male) | 1.1 (0.4) | 2.9 (1.4–5.9) | 0.004 |
| Symptom duration | 0.05 (0.02) | 1.1 (1.0–1.1) | 0.002 |
| On treatment | −0.3 (0.4) | 0.7 (0.4–1.5) | 0.383 |
| Previous dilation (Yes) | 0.6 (0.3) | 1.9 (1.0–3.5) | 0.038 |
| Eosinophil count | 0.01 (0.01) | 1.0 (1.0–1.0) | 0.208 |
| Eosinophil count <15/hpf | −0.44 (0.34) | 0.6 (0.3–1.3) | 0.202 |
| EREFS total score | 0.2 (0.1) | 1.3 (1.1–1.5) | 0.005 |
| EREFS Fibrotic score | 0.6 (0.2) | 1.9 (1.3–2.7) | <0.001 |
| EREFS Inflammatory score | 0.2 (0.1) | 1.2 (0.9–1.5) | 0.162 |
| Stricture (Yes) | 0.3 (0.4) | 1.4 (0.7–2.9) | 0.409 |
| Distensibility plateau | −0.2 (0.5) | 0.8 (0.7–0.9) | <0.001 |
| Distensibility plateau <17mm | 1.0 (0.3) | 2.7 (1.5–4.9) | 0.001 |
| Distensibility plateau <13mm | 2.1 (0.5) | 8.4 (3.3–21.1) | <0.001 |
| EGJ-distensibility index (DI) | −0.5 (0.1) | 0.6 (0.5–0.7) | <0.001 |
| EGJ-DI <2.0 mm 2 /mmHg | 1.8 (0.3) | 6.2 (3.2–12.0) | <0.001 |
| Maximum EGJ diameter (FLIP) | −0.4 (0.1) | 0.7 (0.6–0.8) | <0.001 |
| >=16mm | ref | ref | |
| FLIP Pressure (greatest fill volume) | 0.013 (0.01) | 1.0 (1.0–1.10) | 0.127 |